Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.

Autor: Moura Barbosa AJ; Department of Chemistry, University of Modena and Reggio Emilia, Via G. Campi 183, 41100 Modena, Italy., De Rienzo F, Ramos MJ, Menziani MC
Jazyk: angličtina
Zdroj: European journal of medicinal chemistry [Eur J Med Chem] 2010 Nov; Vol. 45 (11), pp. 4746-60. Date of Electronic Publication: 2010 Jul 27.
DOI: 10.1016/j.ejmech.2010.07.039
Abstrakt: Inhibition of the 5-hydroxytryptamine receptor (5-HT(3)R), a member of the Cys-loop superfamily of Ligand-Gated Ion Channels (LGICs), has been recognized to have important antiemetic effects. With respect to the many other drugs already in use, such as the first generation 5-HT(3)R antagonist granisetron, palonosetron, a second generation antagonist, clearly demonstrates superior inhibition potency towards the 5-HT(3)Rs. Five different receptor monomers, the 5-HT(3)R A-E, have been identified although the A and B subunits are the only known to build functional receptors, the homopentameric 5-HT(3A)R and the heteropentameric 5-HT(3B-A)R (with BBABA subunit arrangement). At present, however, no three-dimensional structure has been reported for any of the 5-HT(3)R subunits. To understand the binding properties of agonists and antagonists, models of the extracellular portion of the 5-HT(3)R A and B subunits are built and assembled into the receptor (homo- and hetero-) pentameric structure on the basis of the known three-dimensional structure of the nicotinic-acetylcholine receptor (nACh-R). The results of docking studies of the natural agonist serotonin and the antagonists palonosetron and granisetron into the modelled homomeric and heteromeric 5-HT(3)R binding interfaces, provide a possible rationalization both of the higher potency of palonosetron with respect to other antagonists, and of its previously reported allosteric binding and positive cooperativity properties.
(Copyright © 2010 Elsevier Masson SAS. All rights reserved.)
Databáze: MEDLINE